N/A
Completed N=3
COVID-19 Close Contact Self-Testing Study
Source: ClinicalTrials.gov NCT04847479 ↗Enrolled (actual)
3
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcomePrimary: Number of Positive Contacts — 0; 0 Participants
Summary
Widespread testing and contact tracing are critical to controlling the COVID-19 epidemic. Distribution of COVID-19 self-test kits can augment public health contact tracing efforts, as individuals with COVID-19 can distribute self-testing to close contacts. This approach can increase case detection by facilitating testing among exposed individuals, and potentially ameliorate stigma, fear, and medical mistrust associated with COVID-19 among vulnerable populations.
The central hypothesis of this study is that distribution of SARS-CoV-2 self-tests to close contacts of among individuals with COVID-19 infection can increase case detection compared with a standard contact referral strategy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Positive Contacts |
0; 0 | — |
| SECONDARY Number of Positive Contacts (End of Study) |
0; 0 | — |
| SECONDARY Number of Contacts Tested |
2 | — |
| SECONDARY Number of Contacts Tested (End of Study) |
0; 0 | — |
| SECONDARY Number of Household Contacts Tested |
0; 0 | — |
| SECONDARY Number of Household Contacts Tested (End of Study) |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years of age or older
- Has a working telephone number
- Willing and able to provide informed consent
Exclusion Criteria
- Severe symptoms requiring immediate medical attention
- Younger than 18 years of age
- Does not have a working telephone number
- Unable or unwilling to provide informed consent
Data sourced from ClinicalTrials.gov (NCT04847479). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.